Thus, a broad spectrum of therapeutic approaches, known as endocrine therapies, has been developed to block or inhibit the estrogen receptors (ER) in BC or the androgen receptors (AR) in PC, or other mechanisms along their respective hormone signaling pathways. Here, ESR1 is linked to breast cancer.